1. Home
  2. LOAR vs NUVL Comparison

LOAR vs NUVL Comparison

Compare LOAR & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAR
  • NUVL
  • Stock Information
  • Founded
  • LOAR 2012
  • NUVL 2017
  • Country
  • LOAR United States
  • NUVL United States
  • Employees
  • LOAR N/A
  • NUVL N/A
  • Industry
  • LOAR
  • NUVL Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOAR
  • NUVL Health Care
  • Exchange
  • LOAR NYSE
  • NUVL Nasdaq
  • Market Cap
  • LOAR 6.3B
  • NUVL 5.6B
  • IPO Year
  • LOAR 2024
  • NUVL 2021
  • Fundamental
  • Price
  • LOAR $94.26
  • NUVL $71.76
  • Analyst Decision
  • LOAR Strong Buy
  • NUVL Strong Buy
  • Analyst Count
  • LOAR 4
  • NUVL 8
  • Target Price
  • LOAR $84.00
  • NUVL $115.50
  • AVG Volume (30 Days)
  • LOAR 730.0K
  • NUVL 660.5K
  • Earning Date
  • LOAR 05-13-2025
  • NUVL 05-08-2025
  • Dividend Yield
  • LOAR N/A
  • NUVL N/A
  • EPS Growth
  • LOAR N/A
  • NUVL N/A
  • EPS
  • LOAR 0.24
  • NUVL N/A
  • Revenue
  • LOAR $402,819,000.00
  • NUVL N/A
  • Revenue This Year
  • LOAR $24.82
  • NUVL N/A
  • Revenue Next Year
  • LOAR $19.15
  • NUVL N/A
  • P/E Ratio
  • LOAR $403.29
  • NUVL N/A
  • Revenue Growth
  • LOAR 26.88
  • NUVL N/A
  • 52 Week Low
  • LOAR $45.13
  • NUVL $55.54
  • 52 Week High
  • LOAR $99.16
  • NUVL $113.51
  • Technical
  • Relative Strength Index (RSI)
  • LOAR N/A
  • NUVL 51.04
  • Support Level
  • LOAR N/A
  • NUVL $63.56
  • Resistance Level
  • LOAR N/A
  • NUVL $78.97
  • Average True Range (ATR)
  • LOAR 0.00
  • NUVL 3.30
  • MACD
  • LOAR 0.00
  • NUVL -0.20
  • Stochastic Oscillator
  • LOAR 0.00
  • NUVL 59.65

About LOAR LOAR HOLDINGS INC

Loar Holdings Inc in the design, manufacture, and sale of niche aerospace and defense components that are essential for today's aircraft and aerospace and defense systems. Its manufactured products includes auto throttles, lap-belt airbags, two- and three-point seat belts, water purification systems, fire barriers, polyimide washers and bushings, latches, hold-open and tie rods, temperature and fluid sensors and switches, carbon and metallic brake discs, fluid and pneumatic-based ice protection, RAM air components, sealing solutions and motion and actuation devices, among others. It operate across ten manufacturing facilities located in the United States, one manufacturing facility in Germany and one manufacturing facility in the United Kingdom (UK).

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: